Get started
Author

Zlatko Sisic

Observed names: Sisic, Zlatko, Z Sisic, Z. Sisic
ORCID: 0000-0001-6043-5581
Observed ORCID: 0000-0001-6043-5581
OpenAlex ID: A5058509591
The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe
2013 · Teresa Caballero, Emel Aygören-Pürsün, et al. · Allergy and Asthma Proceedings · 217
Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe
2014 · Emel Aygören-Pürsün, Anette Bygum, et al. · Orphanet Journal of Rare Diseases · 147
PDF
Burden of Illness in Hereditary Angioedema: A Conceptual Model
2015 · A Bygum, E Aygören-Pürsün, et al. · Acta Dermato Venereologica · 114
Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema
2016 · Emel Aygören-Pürsün, Anette Bygum, et al. · Patient Preference and Adherence · 58
PDF
Cervical cord compression in mucopolysaccharidosis VI (MPS VI): Findings from the MPS VI Clinical Surveillance Program (CSP)
2016 · Guirish A. Solanki, Peter P. Sun, et al. · Molecular Genetics and Metabolism · 44
PDF
Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open‐label, phase 2 study
2016 · Paul R. Harmatz, Eugen Mengel, et al. · American Journal of Medical Genetics Part A · 33
PDF
Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2)
2021 · Paul Gissen, Nicola Specchio, et al. · Orphanet Journal of Rare Diseases · 18
PDF
Pregnancy in patients with mucopolysaccharidosis: a case series
2016 · Fiona J. Stewart, Andrew Bentley, et al. · Molecular Genetics and Metabolism Reports · 17
PDF
Enzyme replacement therapy outcomes across the disease spectrum: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program
2019 · Paul R. Harmatz, Christina Lampe, et al. · Journal of Inherited Metabolic Disease · 15
PDF
Enzyme replacement therapy initiated in adulthood: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program
2019 · Christina Lampe, Paul R. Harmatz, et al. · Molecular Genetics and Metabolism · 11
PDF
Acetylator Status Impacts Amifampridine Phosphate (Firdapse™) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function
2017 · Peter E. Haroldsen, Zlatko Sisic, et al. · Clinical Therapeutics · 10
PDF
Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States
2021 · Siu Hing Lo, Andrew Lloyd, et al. · PharmacoEconomics - Open · 9
PDF
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom
2025 · Sara E. Mole, Paul Gissen, et al. · Orphanet Journal of Rare Diseases · 6
PDF
Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data
2024 · Nicola Specchio, Paul Gissen, et al. · PLoS ONE · 3
PSY17 Time Trade-Off Utilities for Hereditary Angioedema Health States
2021 · S.H. Lo, A. Lloyd, et al. · Value in Health · 1
Enzyme replacement therapy in patients with mucopolysaccharidosis type VI: Updated findings from the MPS VI clinical surveillance program
2019 · Paul Harmatz, Christina Lampe, et al. · Molecular Genetics and Metabolism · 1
Mucopolysaccharidosis type VI enzyme replacement therapy initiated in adulthood: Findings from the MPS VI clinical surveillance program
2018 · Paul Harmatz, Christina Lampe, et al. · Molecular Genetics and Metabolism · 1
Expert Opinions on Managing Fertility and Pregnancy in Patients With Mucopolysaccharidosis
2016 · Fiona Stewart, Andrew Bentley, et al. · Journal of Inborn Errors of Metabolism and Screening · 1
PDF
Mucopolysaccharidosis type VI enzyme replacement therapy outcomes across the disease spectrum: findings from the MPS VI clinical surveillance program
2018 · Paul Harmatz, Christina Lampe, et al. · Molecular Genetics and Metabolism
Impact of elosulfase alfa in patients with Morquio syndrome type A who have limited ambulation: An open-label, phase 2 study
2016 · Paul R. Harmatz, Andrea Jester, et al. · Molecular Genetics and Metabolism
Pregnancy in individuals with mucopolysaccharidosis (MPS): A case series
2016 · Fiona Stewart, Paul Harmatz, et al. · Molecular Genetics and Metabolism
Management of fertility and pregnancy in individuals with mucopolysaccharidosis (MPS)
2016 · Fiona Stewart, Paul Harmatz, et al. · Molecular Genetics and Metabolism
Works count: 26
Citation count: 706
H-index: 10
I10-index: 11
Year
Topic
Type